Predicting Poor Efficacy of Cabozantinib in Advanced Renal Cell Carcinoma by Exploratory Metabolic Pathway Analysis and In Vitro Verification

Takanari Sakai, Yoshihide Kawasaki, Izumi Sakamoto, Eiji Hishinuma, Naomi Matsukawa, Daigo Chiba, Tomonori Sato, Kento Morozumi, Masamitsu Maekawa, Nariyasu Mano, Akihiro Ito · 2026

Read Predicting Poor Efficacy of Cabozantinib in Advanced Renal Cell Carcinoma by Exploratory Metabolic Pathway Analysis and In Vitro Verification by Takanari Sakai, Yoshihide Kawasaki, Izumi Sakamoto, Eiji Hishinuma, Naomi Matsukawa, Daigo Chiba, Tomonori Sato, Kento Morozumi, Masamitsu Maekawa, Nariyasu Mano, Akihiro Ito (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13428040.txt.

Description

Sakai and colleagues hunt in blood chemistry for signs that cabozantinib, a key drug for advanced kidney cancer, will fail a patient before it starts. Response varies widely, and months lost on a futile drug cost survival. Their 2026 exploratory study profiles the set of small molecules in pre treatment serum from nineteen patients with clear cell kidney cancer, split by outcome. It then checks the candidate signals in drug resistant kidney cancer cell lines made in the lab from three sources.

Seven metabolic pathways separated poor responders from responders, spanning histidine, caffeine, tryptophan, and purine chemistry. Five metabolites carried the signal, including xanthine and kynurenic acid. The pathways and metabolites showed up in the resistant cell lines, which strengthens the case that the blood pattern reflects tumor behavior rather than noise. With nineteen patients, the authors frame the panel as a candidate predictor that larger cohorts must confirm.

Catalog record

CREATORTakanari Sakai, Yoshihide Kawasaki, Izumi Sakamoto, Eiji Hishinuma, Naomi Matsukawa, Daigo Chiba, Tomonori Sato, Kento Morozumi, Masamitsu Maekawa, Nariyasu Mano, Akihiro Ito
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13428040

Browse the full library · About the Tower of Babel